Emergency icon Important Updates

David Flannery, MD

David Flannery, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Center for Personalized Genetic Healthcare
Primary Location Cleveland Clinic Main Campus
Type of Doctor Both Adults and Children & Adolescents
Languages English
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.636.1768
Desk:
216.444.9249
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About David Flannery, MD

David B Flannery, MD, is the Director of Telegenetics and Digital Genetics, as well as a Staff Physician in Cleveland Clinic’s Genomic Medicine Institute. He sees patients on Main Campus and via telegenetics technology. 

Dr. Flannery is certified by the American Board of Pediatrics and the American Board of Medical Genetics. Dr. Flannery completed his bachelor’s degree in psychology from Columbia University, and received his medical degree from Emory University. He completed his pediatrics residencies at the Emory University Affiliated Hospitals and the University of Virginia, and his fellowship in human genetics at the Medical College of Virginia. Dr. Flannery also earned a post-graduate certificate in Health Services Research and Health Economics from the Medical College of Georgia. He is board-certified in both Clinical Genetics and Pediatrics. 

A physician leader with a national reputation for shaping the policy and practice of medical genetics, Dr. Flannery has been a key figure in driving the adoption of telegenetics solutions. He has also been active internationally, representing the American Academy of Pediatrics on the World Health Organization’s Topic Advisory Group for the development of ICD-11 codes for genetics, as well as on the Pediatric Task Team of the Global Alliance for Genomics and Health. Dr. Flannery also served as an accreditation site visitor for the American Board of Genetic Counseling, and holds leadership positions with the American Medical Association. 

Dr. Flannery has nearly 40 years of clinical experience, including appointments at the University of Virginia’s School of Medicine and the Medical College of Georgia at Augusta University, and has published extensively in clinical genetics, telemedicine and dysmorphology, and is a frequent presenter at national meetings. Most recently, Dr. Flannery served as Medical Director of the American College of Medical Genetics and Genomics, the National Coordinating Center for Regional Genetics Collaboratives, and the Newborn Screening Translational Research Network.  

His specialty interests include general genetics, pediatric genetics, prenatal genetics, cardiovascular genetics, cancer genetics, telemedicine, and telegenetics.

Education & Professional Highlights

Education & Professional Highlights

Appointed
2018

Education & Fellowships

Fellowship - Virginia Commonwealth University Medical College
Human Genetics
Richmond, VA
1983

Residency - University of Virginia Health System
Pediatrics
Charlottesville, VA
1979

Residency - David Flannery
Pediatric Residency
Decatur, GA United States
1978

Medical Education - Emory University School of Medicine
Atlanta, GA
1976

Undergraduate - Columbia University
New York, NY
1972

Certifications

  • Medical Genetics and Genomics - Clinical Genetics
  • Pediatrics
Research & Publications

Research & Publications

See publications for David Flannery, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/8/2024, Dr. Flannery has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top